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To determine the structure of Amb a I (previously 
called  antigen E), the major allergen from short rag- 
weed, cDNA from pollen was cloned into Xgtll and 
XgtlO. One of the  three distinct clones isolated from 
the Xgtll library by screening with anti-denatured 
Arnb a I antibodies was used to screen both libraries 
for other Amb a I sequences. Multiple clones were 
isolated and sequenced and proved to be highly homol- 
ogous but nonidentical. The clones could be divided 
into three groups based on sequence similarity, and in 
accordance with the International Union of Immuno- 
logical Societies-approved nomenclature (Marsh, D. 
G., Goodfriend, L., King, T. P., Lowenstein, H., and 
Platts-Mills, T. A. E. (1986) Bull. WHO 64,767-770) 
they  have been designated Amb a I.1, Amb a 1.2, and 
Amb a 1.3. Clones within a group have  greater than 
99% identity, and similarity among groups is  85-90% 
at the nucleotide level.  The amino acid sequence of four 
peptides (isolated from antigen E obtained from the 
Research Resources Branch of the National Institutes 
of Health) containing 132 amino acids  was identical to 
one of the clones (Amb a I .  I ) .  The presence of multiple 
naturally occurring isoelectric forms of Amb a I was 
demonstrated by two-dimensional gel electrophoresis 
and Western blotting. Southern blot analysis demon- 
strates  the presence of multiple Arnb a I-related se- 
quences in the ragweed genome. Amb a I is therefore 
not a single molecule but rather a family of closely 
related proteins. 
Of all the  seasonal aeroallergens,  pollen  from short ragweed 
(Ambrosia  artemisiifolia) is  perhaps  the  most clinically impor- 
tant.  The extremely small  particle size allows this pollen to 
be  carried  hundreds of miles, and  it  is  the major cause of late 
summer hay fever in  the  eastern  United  States  and  Canada 
(2). Of the 52 antigens  present  in  an queous extract of pollen, 
at least 22 are allergens  defined  by their reactivity with  human 
IgE  (3). At least five significant human allergens  from short 
ragweed pollen  have  been  purified to homogeneity and  studied 
with respect to  their biochemical and immunological charac- 
teristics (2). 
Antigen  E or A m b  a I (according to  nomenclature  in Ref. 
1) is considered the most important allergen since 95% of 
ragweed-sensitive individuals react to it in skin tests and 
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show  high  IgE antibody  titers  to  it (4, 5 ) .  A m b  a I is highly 
abundant, comprising about 6% of the total protein in a 
neutral aqueous extract of pollen (4). It  is  an acidic, amino- 
terminal “blocked,” reportedly nonglycosylated single-chain 
protein of 38  kDa which  undergoes  proteolysis during  chro- 
matographic purification and is cleaved into two chains, a 
and p, of  26 and  12 kDa,  respectively (6).  The two-chain form 
is  reported  to be  allergenically and antigenically indistinguish- 
able from the  intact molecule, but modification of the  protein, 
including reduction and alkylation of disulfide bonds, urea 
denaturation  and  renaturation, or succinylation of lysine  res- 
idues,  reduces the IgE immunoreactivity of the molecule (2). 
Recent  data  with  Western  blotting  demonstrate  that A m b  a I 
retains  the  ability  to  bind  antibody from allergic humans  and 
hyperimmunized animals  (documented  in Fig. 3 and  Footnote 
1). 
It  has been reported  that  immunotherapy utilizing  purified 
A m b  a I is as effective in alleviating clinical symptoms in 
allergic patients as is immunotherapy using whole pollen 
extract (7). Immunizations with modified forms of A m b  a I 
have  also  been tested  and shown to be as clinically effective 
as  native A m b  a I and  to cause fewer systemic  reactions (8- 
11). A m b  a I has been  shown to have three nonoverlapping, 
nonrepeated  antigenic  sites,  as defined by murine monoclonal 
antibodies, of which at  least two represent major human 
allergenic epitopes (12). In  addition,  preliminary  studies  di- 
rected at examining T cell epitopes of A m b  a I suggest that 
they  are  linear  rather  than  conformational (13-15). 
At present, desensitization immunotherapy for ragweed- 
allergic individuals relies upon multiple injections of small 
doses of aqueous  pollen extracts.  These protocols are  not ideal 
since individuals present  with varying  sensitivities to each of 
the  multiple  components  in  an  extract,  and various batches 
of extract used  for  diagnostic and  therapeutic purposes  vary 
a great deal in  their specific allergen content.  Furthermore, 
although  immunotherapy offers  some improvement  to  many 
patients, almost no patients become completely asympto- 
matic,  and a number of patients show no  symptomatic  im- 
provement a t  all (16).  Identification  and  characterization of 
specific epitopes of A m b  a I might be particularly useful in 
improving an immunotherapeutic approach to desensitiza- 
tion. 
As a first  step  toward  this  end, cDNA  libraries  have  been 
constructed from short ragweed pollen and whole flowers. 
This  report describes the cloning of A m b  a I and  presents  the 
complete nucleotide and deduced amino acid sequences of 
three clones  coding  for this 398-amino  acid allergen. Compar- 
ison of the three cloned sequences shows that they have 
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several differences, suggesting that Amb a I is actually a family 
of proteins with at least three members. These  proteins rep- 
resent an as yet undescribed family since a search of available 
data bases shows  no significant homology to other  proteins 
from either procaryotes or eucaryotes. Finally, in contrast to 
what has been reported in the literature (6), the carboxyl 
terminus of Amb a Z appears to be cysteine. During this 
investigation, a peptide corresponding to  the predicted car- 
boxyl terminus of Arnb a Z was isolated from chromatograph- 
ically purified Amb a Z, confirming the assignment of cysteine 
as the carboxyl-terminal amino acid. 
MATERIALS AND  METHODS 
JB4F3-5, JB3C9-3, JBlE3-4, 2D8/E6, JB4E3-3, JB4E6-4, and 
Antibodies-Mouse monoclonal anti-denatured Amb a I antibodies 
IBlE2-2 have been described previously (17). 
Plant Tissue-Flowers and leaves of short ragweed were picked, 
frozen immediately in liquid nitrogen, and stored at -70 "C until 
processing. Defatted short ragweed pollen and meadow fescue pollen 
were obtained from Greer Laboratories (Lenoir, NC). 
Genomic  DNA Isolation-Genomic  DNA  was isolated by a method 
published previously (18) with the following changes. 50-100 g of 
frozen ragweed  flowers  were ground in liquid nitrogen using a  mortar 
and pestle. The dry powder  was suspended in homogenization buffer 
(0.2 M Tris-HC1, pH 8.5,  0.2 M sucrose, 6 mM KCl, 50 mM MgCl,,  5.8 
mM 2-mercaptoethanol, 2% (w/v) polyvinylpyrrolidone 40 and ho- 
mogenized at high speed with a Polytron homogenizer (Brinkmann 
Instruments) for 3 min. The DNA was banded two times on CsCl 
gradients to obtain DNA that could be digested by restriction enzymes 
(21). 
RNA Isolation-RNA  was isolated from 10 g of defatted ragweed 
pollen or  whole  flowers  by a slightly modified method published by 
Lagrimini et al. (19). After the original phase separation, the nucleic 
acids were precipitated in the presence of  0.3 M sodium acetate and 
75% ethanol at -20 "C for at least  4 h. The precipitate was pelleted 
by centrifugation at 13,000 X g for 20 min and  the pellet dissolved in 
2 ml of sterile water. The RNA  was then precipitated selectively in 
the presence of 3 M LiCl at -20 "C overnight. The precipitate was 
pelleted as before. 
The RNA pellet was dissolved in 1 ml  of oligo(dT) binding buffer 
(10 mM Tris-HC1, pH 7.5,0.5 M NaCl, 0.5%  SDS,' 1 mM EDTA)  and 
poly(A+) RNA selected on oligo(dT)-cellulose (Collaborative Re- 
search). 60  pg  of hydrated oligo(dT)-cellulose was added to the 
sample, heated to 55 "C for 1 min,  and mixed gently at room temper- 
ature for  10  min. The resin was centrifuged for 5 s in a microcentri- 
fuge, the supernatant poured off, and  the sample washed three times 
with fresh binding buffer before being eluted with 2 X 300  pl of elution 
buffer (10 mM Tris,  pH 7.5,  0.5% SDS, 1 mM EDTA). The poly(A+) 
RNA  was precipitated with 0.01  volume of 3 M sodium acetate and 
2.5 volumes of ethanol. 
Isolation and Characterization of cDNA Clones-A Xgtll library 
was generated from cDNA made from pollen mRNA using avian 
myeloblastosis virus reverse transcriptase (Life Sciences) and RNase 
H (Boehringer Mannheim) as described (20). After methylation with 
EcoRI methylase (Bethesda Research Laboratories), cDNA was li- 
gated with phosphorylated EcoRI linkers (Bethesda Research Labo- 
ratories), digested with EcoRI, and excess linker removed from the 
cDNA on a Sephadex (2-100 column (Pharmacia  LKB Biotechnology 
Inc.). The cDNA  was ligated into dephosphorylated Xgtll arms 
(Promega Biotech, Madison, WI), packaged with the Gigapack pack- 
aging system (Stratagene Cloning Systems), and plated using stand- 
ard procedures (21). The library was plated on 150-mm Petri dishes 
at a density of  20,000-30,000 plaques/plate and screened with a pool 
of monoclonal  mouse antidmb a I antibodies using the Protoblot  kit 
(Promega Biotech). Antibodies from ascites fluids were prepared by 
preabsorption with filters of nonrecombinant X plaque lifts and used 
at  a dilution of  1:5000. Three antibody-binding clones were purified 
by repeated plating (two to four times), subcloned into M13mp19, 
and sequenced using the dideoxy sequencing method (22). One of 
these clones, Amb a I.2, was radiolabeled and used to rescreen the 
The abbreviations used are: SDS, sodium dodecyl sulfate; PAGE, 
polyacrylamide gel electrophoresis; Tricine, N-[2-hydroxy-l,1- 
bis(hydroxymethyl)ethyl]glycine; CAPS, 3-[cyclohexylamino]-l-pro- 
panesulfonic acid PCR, polymerase chain reaction. 
library for related nucleotide sequences. This screening yielded six 
independent additional clones. 
A X g t l O  library containing cDNA inserts from short ragweed  flower 
head mRNA was prepared according to published procedures (23,24) 
using an Amersham Corp. cDNA cloning kit. Approximately 8 X lo4 
independent clones were screened by standard procedures (25) using 
nick-translated (26) 32P-labeled Amb a 1.2 cDNA as a probe. Four 
independent hybridizing cDNA clones were isolated and subcloned 
into M13 for dideoxynucleotide sequencing (22). 
Northern Blotting and Hybridizations-20 pg of total RNA was 
electrophoresed through a formaldehyde-containing gel, blotted onto 
nitrocellulose paper, and hybridized to a radiolabeled cDNA clone 
according to standard procedures (21). Posthybridization washes  were 
done in 2 X SSC, 0.1% SDS, first at room temperature for 15 min, 
and  then for 1 h at 50 "C. The filter was air dried and exposed to 
Kodak XAR  film at -70 "C with an intensifying screen. 
Southern Blot  Analysis-Digestion of genomic  DNA, agarose gel 
electrophoresis, and blotting  onto nitrocellulose were done by con- 
ventional methods (21). The filters were hybridized to nick-translated 
cDNA clones. Hybridization and washing conditions were the same 
as those used for RNA blots. 
Protein Purification and Sequencing-Amb a I protein sequence 
data were obtained from one chromatographic form of  Amb a I (AgE- 
B) generously provided by Dr. T. P. King (Rockefeller University, 
New York) and from the Amb a Z protein, which was purified 
according to  the method of King et al. (6) with certain modifications. 
In brief, the defatted short ragweed pollen (Greer Laboratories) was 
extracted in 50 mM Tris, pH 8.0, containing 0.1 mM phenylmethyl- 
sulfonyl fluoride, 1 pg/ml leupeptin, 10 pg/ml pepstatin,  and 10 pg/ 
ml soybean trypsin inhibitor. After decolorization with DE52  cellulose 
(Whatman)  the extract was fractionated by ammonium sulfate pre- 
cipitation. The 45-59% saturation fraction was purified further by a 
Sephacryl S-200 (Pharmacia) column and Mono Q (Pharmacia) an- 
ion-exchange column. The Amb a I protein purified by this modified 
method appeared as a single band of 38 kDa on SDS-polyacrylamide 
gel electrophoresis (SDS-PAGE). The majority of amino acid se- 
quence data was derived from mixtures of peptides produced either 
by cyanogen bromide (CNBr) or formic acid (29) cleavage of the AgE- 
B or  Amb a I. The peptide mixtures were treated  in the sequenator 
with o-phthalaldehyde to block all primary amines when a proline 
was known to be present at the amino terminus (30), which was 
identified in an exploratory analysis of the peptide mixtures. One of 
the peptide mixtures derived from a CNBr digest and  an aliquot of 
AgE-B was subjected to SDS-PAGE. The SDS-PAGE was run on a 
precast 10-20% Tricine minigel (Novex) run at 100 volts for 1.5 h. 
Proteins were transferred to polyvinylidene difluoride membrane 
(Millipore) in 10 mM CAPS buffer, pH 11, at 150 mA for 2 h (27). 
The polyvinylidene difluoride was stained with Coomassie  Blue. The 
12-kDa chain band from AgE-B (6) and a 10-kDa band from the 
CNBr digest were cut  out for protein sequencing. Protein sequencing 
was performed on an Applied Biosystems model 477A gas-phase 
sequenator with on-line phenylthiohydantoin derivative analysis 
(model 120). The protein was alkylated in situ in the sequenator by 
using the nonnucleophilic reductant, tributylphosphine, with concom- 
itant alkylation by 4-vinylpyridine in ethylmorpholine buffer (28). 
Two-dimensional Western  Blot-Isoelectric focusing was per- 
formed on a Hoefer gel apparatus with 15 pg  of crude soluble pollen 
protein. The gel consisted of  7.5% acrylamide with 3.5% Pharmalytes, 
pH 4.5-5.3 (Pharmacia) and 3.5% Ampholines, pH 3.5-10 (LKB), 
run at 13  watts for 3.5 h  until  a  constant voltage was reached (31). 
The gel section was placed on a slab of 10% acrylamide SDS-PAGE 
and electrophoresed for 3.5 h at 40  mA according to  the protocol cited 
(32). The proteins were transferred overnight in phosphate buffer (20 
mM NaP04/NaH2P0,  pH 6.8) to 0.1-pm nitrocellulose (Schleicher 
& Schuell) at 0.2 A (33). The blot was rinsed in blot solution (25 mM 
Tris-HC1, pH 7.5,  0.171 M NaCl, 0.05% Tween 20; Sigma). The first 
antibody incubation was overnight at room temperature with a 1:lOOO 
dilution of goat anti-Amb a Z IgG in blot solution. The excess first 
antibody was removed with three 15-min rinses with blot solution. 
The second antibody was a 1:2500 dilution of biotinylated swine anti- 
goat IgG (Boehringer Mannheim)  in blot solution for 2 h. The blot 
was then rinsed with blot solution three times (15 min each) and 
incubated for 1 h in blot solution with '*'I-streptavidin (2 pci, 
Amersham Corp.). The blot was rinsed with blot solution until the 
waste wash returned to background. The blot was then exposed to 
film at -80  "C overnight. 
Sequence-specific  Amplification of Amb a I cDNA with PCR-4 g 
of defatted pollen (Greer Laboratories) was ground with a  mortar  and 
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pestle in 4 M guanidinium isothiocyanate buffer and total RNA 
isolated by standard procedures (34). 
Priming oligonucleotides (Table I) for DNA amplification (35) 
were  RW38, RW32, RW45, and anchor primer. RW38 corresponded 
to the  amino-terminal coding strand sequence encoding amino acids 
Leu-Tyr-Phe-Thr-Leu  (amino acids 10-14). The RW38 sequence was 
conserved between Amb a 1.2 and Amb a 1.3. RW32, which corre- 
sponded to  the noncoding strand sequence between 12 and 39 nucle- 
otides 3' of the TAA stop codon, was specific to Amb a 1.1. RW45 
corresponded to  the noncoding strand sequence complementary to 
amino acids Ile-Lys-Ser-Asn-Asp-Gly (amino acids 181-186)  of  Amb 
a I .  Two additional primers, anchor  template and anchor linker, were 
used for linking to cDNA. The anchor primer oligomer sequence was 
contained within the anchor  template sequence. The anchor linker 
oligomer  was phosphorylated (see Table I for specific sequences and 
restriction sites). These oligonucleotides were purchased from Re- 
search Genetics (Huntsville, AL). 
First-strand cDNA  was synthesized from 1 pg of total RNA with 
the cDNA Synthesis System Plus kit (Amersham Corp.) using 
poly(dT)  as a primer. The single-stranded DNA (20 pl) was mixed 
with 100  pmol of each priming oligo, RW38 and RW32,  10  pl of 10 X 
reaction buffer (GeneAmp kit, U. S. Biochemicals), and 0.5 pl of 
Thermus aquaticus polymerase (U. S.. Biochemicals). The mixture 
was brought to 100  pl with distilled water and overlayed with mineral 
oil (Sigma). The sample was amplified with a programmable thermal 
controller from MJ Research, Inc. (Cambridge, MA). The first five 
rounds of amplification consisted of denaturation at 94  "C for 1 min, 
annealing of primers to  the template at 45  "C for 1.5 min, and chain 
elongation at 70 "C for 4 min. The final 20 rounds of amplification 
consisted of denaturation as above, annealing at 55 "C for 1.5 min, 
and elongation as above. 
Amplified DNA was recovered by sequential chloroform, phenol 
and chloroform extractions followed by overnight precipitation at 
4 "C  with  0.5  volume of 7.5 M ammonium acetate and 1.5  volumes of 
isopropyl alcohol. DNA  was digested simultaneously with EcoRI and 
PstI and electrophoresed on a 1% GTG agarose (FMC, Rockland, 
ME) preparative gel. The predicted 1.2-kilobase band was isolated 
and recovered by glass bead adherence (Geneclean kit, BIO101, La 
Jolla, CA). The digested DNA  was ligated into EcoRIIPstI-digested 
M13 for dideoxy sequencing (22). 
The very 5' end sequence of Amb a I was determined using a 
modification of the anchored PCR (36). Double-stranded cDNA  was 
synthesized from 1 yg  of RNA with the cDNA Synthesis System Plus 
kit using poly(dT) as a primer, blunt ended with T4 polymerase, and 
blunt  end ligated to self-annealed anchor  template and anchor linker 
primers. Linked cDNA (3 yl) was  mixed with 100 pmol of the anchor 
primer and RW32 primers, 10 p1 of 10 X reaction buffer and 0.5 pl of 
T. aquaticus polymerase. The mixture was brought to 100 p1 and 
amplified as described above. 1% of the volume of the primary PCR 
was reamplified with anchor primer and RW45 oligomers. RW45 is 
nested (internal) relative to oligomer  RW32 used in the primary PCR. 
Amplified  DNA  from the secondary PCR corresponding to  the 5' end 
RW45 sequence was recovered as above, digested with KpnI, and 
ligated into KpnIIHincII-digested M13 for dideoxy sequencing (22). 
RESULTS 
Three clones were isolated from a Xgtll ragweed pollen 
cDNA  library  by  screening  with a pool of seven  mouse  mono- 
clonal antibodies raised t o  denatured Amb a I. The  sequences 
of all three of these clones showed extensive homology to 
peptides  isolated  from  highly purified Amb a I. One of these 
clones (Arnb a 1.2) was  radiolabeled and used to screen  this 
library and a X g t l O  library constructed from cDNA made  from 
whole  ragweed  flowers,  resulting in the  isolation of 10 addi- 
tional clones. 
All the  clones  sequenced could be divided into three groups, 
Amb a 1.1, Amb a 1.2, and Amb a 1.3, in  which  clones  within 
a group share greater than 99%  identity, and identity  among 
groups ranges from 85 to 90% at the nucleotide level. T h e  
DNA sequences of the  three largest  prototypic  clones in each 
group are shown in Fig. 1. The longest clone, a member of the 
Amb a 1.3 group, is 1331 bases long, has 13 nucleotides 
preceding the putative ATG start codon at position 1, an 
unbroken reading frame of 1190 nucleotides ending with a 
TAA stop  codon, and a 125-nucleotide  untranslated  AT-rich 
region  before  the  poly(A)  addition  site.  The  other  clones start 
at positions -2 a n d  44 relative  to  the Amb a 1.3 prototype 
start site and have unbroken reading  frames  extending to a 
stop  site  identical  to that found  in  the Amb a 1.3 group. The 
traditional mammalian consensus sequence for polyadenyl- 
ation, AATAAA, does not occur in the untranslated regions. 
T h e  Amb a 1.2 group has a nucleotide  triplet at position 118 
which is not present in   the  Amb a 1.3 and Amb a 1.1 groups, 
and the  Amb a 1.1 group  lacks an additional triplet at position 
101 relative  to the other  two  groups of clones.  Since  only a 
single  non-full-length  clone  representing the Amb a 1.1 group 
was  originally  isolated  from the libraries,  the full-length clone 
was obtained by sequence-specific amplifications of pollen 
RNA using Taq polymerase and synthetic DNA primers.  The 
amino-terminal  primer  corresponded  to  coding  sequence  nu- 
cleotides 25-44 in clone Amb a 1.3 and was conserved  between 
the  Amb a 1.2 and Amb a 1.3 groups. The  carboxyl-terminal 
primer  was  specific  to Arnb a 1.1 and corresponded  to the 3'- 
noncoding  sequence  between 12 and 29  nucleotides 3' of the 
TAA stop codon in that particular clone. The very 5' end 
sequence of Amb a 1.1 was  determined  using  anchored PCR 
methodology. In this  case, the amino-terminal  primer  corre- 
sponded  to a synthetic  linker  sequence. The carboxyl-terminal 
primer described  above was used  in a primary  amplification 
whereas a carboxyl-terminal primer corresponding to the 
noncoding strand sequence for amino  acids 181-186 was  used 
in  a secondary  amplification. A secondary  amplification  using 
a nested  primer was necessary  since the primary  amplification 
TABLE I 
Nucleotide  sequence of oligomers  used in the PCR 
RW32,  RW38, and RW45 correspond to  the coding or noncoding strand sequence of  Amb a I. RW32  is  Amb a 
I.1 specific. Anchor primer (AP),  anchor linker (AL), and anchor  template (AT) do not correspond to Amb a I 
sequences. Nucleotide numbers correspond to those in Fig. 1. Restriction sites  are underlined. 
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Nucleotide sequences of short ragweed clones Amb 
a 1.3, Amb a 1.2, and Amb a 1.1. Numbering begins with the 
adenosine of the ATG initiation codon of clone Amb a 1.3. The  start 
codon and TAA stop codon are ouerscored. Horizontal bars 
(- - -) represent identity to clone Amb a Z.2; a dotted line (. . . .  . )  
indicates no sequence information; asterisks (*) mark positions at 
which nucleotides are absent when compared with the other se- 
quences. Lower cme letters 3' in the clone Amb a 1.2 indicate the 
sequence of the 3' oligonucleotide used for its amplification. The 
poly(A) tails of the clones are  not shown. Solid lines (-) indicate 
the positions of the oligomers used in the PCR. 
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FIG. 1-continued 
did not yield a discrete product band. Sequence identities at 
the nucleotide level in the coding regions are 91% between 
clones Amb a 1.3 and Amb a 1.2 and 86% between Amb a 1.2 
and Amb a 1.1 and between Amb a 1.3 and Amb a 1.1. 
Amino acid sequence data  are presented in Fig. 2. Sequences 
derived from chromatographically purified Amb a I accom- 
pany translated amino acid sequences of the three prototype 
clones. Approximately 130 amino acids were identified from 
four peptides. Two of the peptides were sequenced after a 
cyanogen bromide cleavage of purified Amb a I, and  it was 
assumed that each follows a methionine. A third peptide was 
sequenced after acid  cleavage (70% formic acid) of the aspartic 
acid-proline bond at position 361. For peptides 277-307 and 
361-398, o-phthalaldehyde was used to block all the potential 
amino-terminal amino acids other than proline before the 
first sequencing cycle. For peptides 171-186, the o-phthalal- 
dehyde blocking was applied before the seventh sequencing 
cycle to obtain the unique sequence between 177 and 186. 
The NH2-terminal  end of this peptide was obtained from the 
10-kDa band that was isolated after SDS-PAGE. The fourth 
sequence was derived from the 12-kDa ,6 chain  band of AgE- 
B. Judging from the yield of protein sequencing analysis, the 
peptide sequence 45-91  was derived from a minor component 
of the p chain band. Thus, 129 amino acids or approximately 
one-third of the coding sequence for Amb a I has been ob- 
tained directly from purified protein. Also in Fig. 2 are  the 
translated sequences for each of the  three prototype clones 
coding for Amb a I. The proteins coded for by these sequences 
are 396-398 amino acids long and each has a clear hydropho- 
bic segment following the initiating methionine. Each group 
has  a single potential glycosylation site at position 37 relative 
to the initiating methionine. The clone representing group 
Amb a 1.1 corresponds most precisely to known amino acid 
sequences of peptides derived from enzymatic and chemical 
cleavages of chromatographically isolated Arnb a 1. The Amb 
a 1.3 and Amb a 1.2 clones differ by as much as 20%  from the 
known amino acid sequence. The deduced amino acid se- 
quences of clones Amb a 1.3 and Arnb a 1.2 are 86% identical 
to each other (92% similarity),  and each has approximately 
76% identity (85% similarity) to  clone Amb a 1.1. Nucleotide 
and amino acid sequence comparisons and calculations were 
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FIG. 2. Comparison of the deduced amino acid sequences of 
clones Amb a 1.3, Amb a 1.2, and Amb a I. 1 peptides. Horizontal 
bars (- - -) represent identity to clone Amb a 1.3; a dotted line 
( . a   a )  indicates no sequence information. Asterisks (*) indicate 
deletions in the amino acid sequences. Unidentified amino acid resi- 
dues from the peptide sequencing are reprsented by  a u. 
performed using programs described  previously (37,38). 
The presence of multiple naturally occurring forms of  Amb 
a Z in pollen  was confirmed by two-dimensional electropho- 
resis of pollen protein extract (Fig. 3). Pollen proteins were 
separated first by charge and then by size, blotted onto 
nitrocellulose, and probed with a goat antidmb a I antiserum. 
Three major and  three minor variants of  Amb a Z at 38 kDa 
could  be detected with isoelectric points of approximately 5.2, 
4.9,4.7,4.3,5.9, and 5.4 in order of decreasing intensity. The 
calculated (from amino acid composition) isoelectric point of 
5.2 of the clone representing Amb a 1.1, along with its perfect 
match to Amb a Z peptides, might suggest that  this clone 
represents the major variant of the allergen isolated from 
pollen  collected  over a wide geographic area. The DNA and 
protein sequences  were compared with sequences in the 
EMBL and NBRF computer data bases.  No significant ho- 
mologies  were  found in  either case. 
Northern blot analysis of RNA  from defatted ragweed and 
meadow  fescue (grass) pollens is depicted in Fig. 4. RNA  was 
probed with a radiolabeled  member of the Amb a 1.2 group. 
Strong binding can be seen to a 1.5-kilobase  message in the 
ragweed pollen RNA, and no binding is demonstrable in 
comparable amounts of RNA isolated from the grass pollen. 
Similar analyses using RNA derived from other ragweed plant 
tissues such as leaves and roots also showed no binding to  the 
Amb a Z probe (data  not shown). 
A Southern blot of genomic DNA digested with various 
restriction enzymes and probed with Amb a 1.2 is shown in 
Fig. 5. The clone binds to multiple bands in all the prepara- 
tions and, when compared with restriction enzyme maps of 
the clones, suggests that there  are multiple genes encoding 
Amb a I in an outbred population of ragweed plants. Whether 
m m m m  
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FIG. 3. Two-dimensional gel electrophoresis and Western 
blotting of pollen protein. Crude, soluble pollen proteins were 
subjected to isoelectric focusing (left to right) followed by 10% SDS- 
PAGE electrophoresis (top to bottom). The proteins were blotted onto 
nitrocellulose and probed with goat antidmb a I antisera. The 26,000- 
dalton band  presumably represents the CY chain of Amb a I. 
" y "  
1 2  
FIG. 4. RNA blot analysis of total RNA from various tissues. 
20 pg of total RNA was electrophoresed, blotted onto nitrocellulose, 
and hybridized to radiolabeled Amb a 1.2. Lane 1, short ragweed 
pollen; lane 2, meadow fescue pollen. 






FIG. 5. DNA blot analysis of short ragweed genomic  DNA. 
Genomic DNA was digested with BamHI (lane I ) ,  EcoRI (lane 2), 
Hind111 (lane 3), and NcoI ( l a n e  4)  and run on a 0.7% agarose gel. 
The DNA was transferred to nitrocellulose and hybridized to radio- 
labeled Amb a 1.2. 
1234 Cloning of Amb a I 
the observed heterogeneity of Amb a I is  due  to allelic varia- 
tion, multiple genes in a single plant, or perhaps both is 
presently  under investigation. 
DISCUSSION 
The use of molecular biology techniques  to  study directly 
the structure-function relationships of allergens of medical 
importance  has only recently begun to be exploited. Thus  far 
three  non-plant allergens  (white-faced hornet venom antigen 
5, bee venom phospholipase A2, and the house dust mite 
allergen Derp I) have been cloned and used  for  immunological 
studies (39-41). In this report, the major allergen of short 
ragweed pollen has been  cloned, and  its complete  nucleic  acid 
and deduced amino acid  sequence are described. This allergen 
(Am6 a I) is shown to  be a  family of proteins, closely related 
to each other  but unique  from other families of proteins. 
Proteins  in  the pollen coat  can  originate  from two different 
sources. They may be expressed in  the pollen  cytoplasm  itself, 
or they  can be synthesized  in  the  tapetal  nursing cells sur- 
rounding  the pollen and  then  deposited  on  the pollen  surface 
(42). cDNA libraries, therefore, were made from poly(A+) 
RNA both from maturing flowers and from commercially 
available defatted ragweed pollen. The pollen cDNA  library 
was  made  in Xgtll and was  screened with a panel of mono- 
clonal  antibodies raised specifically against  denatured Am6 a 
I. From the information gained by cloning and sequencing 
Am6 a I from this  library,  it was possible to probe a flower 
cDNA library  made in X g t l O .  In addition, once  sequence 
information was derived, it became  possible to design oligo- 
nucleotide primers  to amplify cDNA coding specifically for 
Am6 a I from ragweed flowers by means of the  PCR  reaction. 
Initially, a pool of seven  monoclonal antibodies raised 
against  denatured Am6 a Z (recognizing both a and (3 chains) 
was used to screen the pollen cDNA library. Three clones 
were isolated and fully characterized.  One of these, Amb a 1.2, 
contained  an  almost complete  coding  sequence  for Am6 a Z, 
another  named Amb a 1.3 contained  approximately  two-thirds 
of the coding  sequence, and  the  third, Am6 a I.1, contained 
320 base pairs  and coded for only 50 COOH-terminal  amino 
acids of Amb a I. Further  screening of the  libraries  (and  PCR 
amplification of cDNA  in  the case of Amb a I.1) has produced 
full-length  sequences of three groups of highly related  struc- 
tures  representing Amb a I. A total of 14 clones were com- 
pletely  sequenced. On average,  clones within  each  group  dif- 
fered at  less than 1% of the nucleotides  coding for the  struc- 
tural  protein while the difference  between  groups  was of the 
order of 10-15% at the nucleotide level. When full-length 
representative clones from  each group are expressed in Esch- 
erichia coli and  the  products  blotted  onto nitrocellulose mem- 
branes for probing  with  monoclonal antibodies  to  denatured 
Am6 a I ,  each gives a unique pattern of reactivity with 
individual antibodies (data not shown). This suggests that 
individual antibodies  are able to  discriminate between  clones 
and  demonstrates  that  all  three groups of Am6 a I proteins 
were in  the chromatographically prepared Am6 a I used to 
originally  immunize the mice. These  three groups of Arnb a I 
clones, therefore, are expressed and are not transcripts of 
nonfunctional genes. 
Multiple isoelectric forms and conservative amino acid 
substitutions  are a  common feature of pollen  allergens that 
have been well characterized  such  as  those from the grasses 
and from short ragweed (4, 43). It was shown earlier (4, 6) 
that Amb a I has four electrophoretic  and/or  structural  forms 
called A, B, C, and D. These  forms  are  indistinguishable by 
amino acid compositional analysis  and comparison of their 
antigenic  and allergenic properties.  In  this  report,  two-dimen- 
sional  Western  analysis of pollen extracts shows three major 
isoelectric forms of Am6 a I and a number of minor  forms 
that differ both  in size and charge. This  is  consistent with the 
description of three groups of Am6 a Z clones and  the  appre- 
ciation  that individual members of a group may differ by as 
much  as 1% from the  prototype  within a group. Current  efforts 
are  directed at  assigning specific groups to specific isoelectric 
forms of Amb a I. It  is  not clear at  this  time  that  the A, B, C, 
and D forms of Am6 a I have  any  direct  relationship  to Am6 
a I.1, Am6 a 1.2, or Am6 a 1.3 as described in  this report. 
Since the pollen used to create the cDNA library was 
collected from a wide geographic area,  it  is unlikely that  other 
major Am6 a Z sequences will be found in short ragweed. 
Current experiments are under way to determine whether 
individual  short ragweed plants collected from various geo- 
graphical locations  in  North America express multiple (or all) 
members of the Am6 a I family or whether individual plants 
show some restricted Am6 a I production. Southern blot 
analysis of genomic DNA clearly  shows  multiple restriction 
fragments identified with a  radiolabeled Am6 a I probe, and 
it will be of interest  to  determine,  in individual plants,  whether 
allelic variation, multiple structural genes, or both  contribute 
to  this  phenomenon. 
Amino  acid  sequence analyses of peptides from chromato- 
graphically isolated Am6 a I have been  obtained.  It is of great 
interest  that  the  best  match of that  amino acid  sequence is 
with  the Am6 a I.1 group of Am6 a I sequences. However, 
despite  exhaustive  screening of several independently derived 
cDNA  libraries, only one  short (320-base pair) clone  belonging 
to  this group was ever  isolated, making  this clone the most 
underrepresented member of the Am6 a I family. A full-length 
clone of Am6 a I.1 was only obtained by sequence-specific 
amplification of pollen  cDNA  using primers specific for the 
3’ end of the original  320-base pair clone and sequences shared 
between Amb a 1.2 and Am6 a 1.3 at the 5’ end.  Three possible 
explanations for this enigma are  currently being  considered. 
First, if it  is  the most  actively transcribed  and/or  translated 
message, it could have a high turnover rate in vivo or be 
particularly  prone  to  degradation  during  storage or processing 
of the pollen. Second, it  is possible that  its  structure could 
somehow interfere uniquely with cDNA synthesis  and cloning 
efficiency, and  its  paucity in the  libraries merely represents a 
technical difficulty. Third,  the Amb a 1.1 protein could in  fact 
be a minor Am6 a I variant  but  be selectively enriched for 
during  the  purification of Am6 a I from pollen extract. 
The  amino acid  composition of the cloned proteins  corre- 
sponds well to  experimental  results  reported previously (4). 
The presence of cysteine as the carboxyl-terminal deduced 
amino acid in all cDNA clones studied is in contrast to a 
report  in which carboxypeptidase  digestion of chromatograph- 
ically purified Arnb a I showed that leucine was the carboxyl- 
terminal  amino acid (6). To  settle  the question of the  car- 
boxyl-terminal residue, the  aspartic acid-proline  peptide bond 
(position 360-361, Fig. 2) of chromatographically purified 
Am6 a I was cleaved by 70% formic  acid. The peptide  sequence 
starting  with  proline was obtained  in  the digestion mixture 
whereas  the nonspecific partially cleaved protein background 
sequence was suppressed by o-phthalaldehyde  treatment.  The 
38-residue peptide sequence obtained corresponded  com- 
pletely with  the deduced sequence of Am6 a I.1 up  to  and 
including the  terminal cysteine. 
Since  the  amino  terminus of Amb a I is “blocked” (6)  and 
not  amenable  to  direct  Edman  degradation,  it is important  to 
be able to conclude that  the clones reported here contain  the 
full  coding  sequence for Am6 a I. Two lines of evidence support 
that conclusion. The experimental evidence comes from a 
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previous study (44) in which primer extension was used to 
add nucleotides to  the 3' end of an oligonucleotide  designed 
from  a  peptide  sequence using flower mRNA  as  template.  The 
5' end of the oligonucleotide corresponds  to nucleotide 249 in 
clone Amb a 1.3 and produced  a cDNA  fragment  about 250 
nucleotides long, suggesting that very little  5'-untranslated 
sequence is missing from  the full-length message. The second 
piece of evidence that  these  are  full-length clones  coding  for 
Amb a 1 comes from a study of the  area  around  the  presumed 
translation  initiation codon AUG (45, 46). From a study of 
211 eucaryotic messages, a consensus sequence has been iden- 
tified at  the  initiation  site.  The sequence contains a purine 
(preferably an A) at position -3, a G at position +4, and a 
predominance of C at  positions -1, -2, -4 and -5. Clone 
Amb a 1.3 has A at  -3, G at +4, and C at  -2. 
There is an obvious hydrophobic stretch of amino acids 
following the  initiating  methionine,  and  this  area  has been 
examined  to  predict  the cleavage site between the hydrophobic 
leader and  the  secreted  protein.  The  prediction  is ba ed upon 
data collected  for 450 secreted eucaryotic proteins (47) with 
known cleavage sites.  Positions -1 and -3 are  most  critical 
for signal  peptide cleavage, and  the  alanine  at  position 26 in 
Amb a 1 best fulfills the  criteria  associated  with  the cleavage 
site.  For  instance, if alanine 26 is indeed  residue +1, then  the 
-1 and -3 positions  are  serine  and  valine, respectively. The 
frequency of those  amino  acids  in  those  positions  in  the  data 
base is two to three times the expected values if random 
amino acids occupied those positions. All amino acids,  from 
-1 through -13, are  consistent  with  the  tabulations from the 
450 known cleavage sites.  Current  efforts  are  under way to 
address directly the  question of how and where the Amb a 1 
proteins  are blocked. 
At the 3' end,  the  untranslated region does not have the 
AATAAA polyadenylation signal observed in most animal 
sequences  located 9-23 bases  upstream from the poly(A) tail. 
However, there is a variant sequence, AATGAA, located 45 
bases  from the poly(A) addition  site, which might serve as  the 
adenylation signal; and another variation of this sequence, 
AAAAAT, is located 39 bases  downstream from the TAA stop 
codon. A similar sequence, AATAAT is located 101 nucleo- 
tides  upstream  from  the polyadenylation site in  clone Amb a 
1.2. Poly(A) signal patterns are known to be much more 
complex in plants  than  animals (48) in  their sequence, num- 
ber, and locations. For example, a pollen-specific sequence 
from maize, Zmol3, reported by Hanson et al. (49), contains 
the  consensus motif AATAAA 180 bases  upstream from the 
poly(A) site  and two variants, AATATA and  AATTAT, lo- 
cated at 55 and 44 bases respectively. Another pollen-ex- 
pressed gene, alcohol dehydrogenase, has  the  AATTAT se- 
quence centered 44 bases upstream from its polyadenylation 
site. 
The  data  presented  in  this  paper fi mly establish  that Amb 
a 1 (antigen E)  is a  family of closely related  proteins.  Experi- 
ments  are  currently  in progress to  address  the relative abun- 
dance of each family  member in pollen, as  mentioned above. 
Just  as  importantly,  it  is necessary to  determine  the  immu- 
nogenicity and allergenicity of the Amb a I family  members. 
It has been possible to express prototypic clones for each 
family member in procaryotic cells.3 This  material  is being 
used  to  compare T cell proliferation  and  IgE  binding from 
individual ragweed allergic patients. This information can 
potentially  be used to devise an  effective course of ragweed 
immunotherapy. 
" J .  Bond, R. Garman, K. Keating, T.  Briner, T. Rafnar, D. Klap- 
per,  and B. Rogers, manuscript  in  preparation. 
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